UPNEEQ

Peak

oxymetazoline hydrochloride ophthalmic

NDAOPHTHALMICSOLUTION/DROPS

Approved

Jul 2020

Lifecycle

Peak

Competitive Pressure

0/100

Loss of Exclusivity

LOE Date

Dec 16, 2039

167 months away

Patent Expiry

Dec 16, 2039

Patent Records (5)

Patent #	Expiry	Type	Use Code
10912765	Aug 26, 2031		U-2849
8357714	Aug 26, 2031		U-2849
9867808	Aug 26, 2031		U-2849
10940138	Dec 16, 2039		U-2849
11103482	Dec 16, 2039	Product	—

External Resources

Full prescribing information

FDA approval history

Drug nomenclature & identifiers